Our mission is to revolutionize disease treatment for patients worldwide with small molecule therapeutics that modify RNA expression
Skyhawk’s potent small molecule drug candidates target RNA across a broad range of neurodegenerative and other challenging diseases
Download logos, brand assets, and other approved materials for media and stakeholder use.
Download the complete logo suite, including approved logo lockups and file formats for print, digital, and presentation use.
Download approved, high-resolution office photograph for editorial, media, and corporate communications use.
